JSA Advocates & Solicitors advised Levim Lifetech Limited on the sale of a 30% stake to Eris Lifesciences Limited for an investment of ₹54 crore
JSA advised Levim Lifetech on this transaction.
The transaction team was led by Varun Sriram (Partner) with support from Bharkavi S (Senior Associate), Associates Nithyashree Venkatesh, Maheema Senthilkumar & Sudha Putrevu.
The acquisition is aimed at expansion of Levim Lifetech's biotechnology footprint across a wide range of products and technologies.
Eris Lifesciences Ltd, established in 2007 and headquartered in Ahmedabad, India, is a publicly listed pharmaceutical company specializing in domestic branded formulations. The company focuses on chronic and sub-chronic lifestyle-related therapies, including anti-diabetes, cardiology, nutrition, and neuropsychiatry.
Levim Lifetech Pvt Ltd is an Indian biotechnology company specializing in the development and commercialization of biopharmaceutical products. The company focuses on leveraging cutting-edge science to bring evidence-based therapies to the market.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.